Presentation is loading. Please wait.

Presentation is loading. Please wait.

VALIDATION AND UPDATING OF MODELS WITH BIOMARKERS

Similar presentations


Presentation on theme: "VALIDATION AND UPDATING OF MODELS WITH BIOMARKERS"— Presentation transcript:

1 VALIDATION AND UPDATING OF MODELS WITH BIOMARKERS
Ewout W. Steyerberg, PhD Center for Medical Decision Making Dept of Public Health Erasmus MC, Rotterdam, the Netherlands Utrecht, March 25, 2009

2 Erasmus MC – University Medical Center Rotterdam

3 Research

4 Contents Praise for Prof. Paul Ridker
Prediction models for better decision making Validation and updating Extension with biomarker(s)

5 Search Google Scholar …

6 Prediction models for better decision making
Identify low and high patients of cardiovascular disease better targeting of preventive interventions Predictions are probabilities No certainty Validation commonly includes calibration and discrimination Systematically too high / too low predictions Poorer performance than hoped for Better predictions with stronger predictors Much interest in biomarkers

7 Case study 1: validity of Framingham risk models
Updating of regression coefficients: refitting Updating to average outcome: re-calibration

8 Validity of Framingham predictions (JAMA 2001)

9 Tab 1

10 Tab 3: Refit

11 Tab 5: Performance Improvement in c e.g  0.70; native Americans even larger gains  ‘substantial improvement by using locally updated coefficients’ Recalibration important for better calibration

12 Case study 2: updating with a biomarker (Circulation 2008)
Refitting of Framingham model Extension with CRP Many statistics to quantify improvement

13

14

15

16

17 Case study 3: updating with a set of biomarkers
Refitting of Framingham model Extension with 4 biomarkers

18 Another example: NEJM 2008

19 Results: focus on c statistic

20 Elderly: mean 71 yrs

21 All markers add significantly, but NT-Pro-BNP is the winner

22 Substantial improvement in c statistics

23 .. and substantial NRI

24 Conclusions Model validation is followed by model updating and model extension Recalibration is a minimum Often new coefficients required Biomarkers need to be strong and beyond discovery phase Incremental contribution to traditional risk factors Be sceptical about new genetic signatures Quantification of model improvement challenging Patterns in C stat and net reclassification index (NRI) coincide No improvement in c  no improvement in NRI Improvement in decisions should be quantified by decision-analytic measures, weighing costs of wrong decisions, e.g. ‘Net Benefit’

25 Read more .. PubMed Paper with attendents of Kattan symposium “Accuracy of prediction models” Books

26 26

27


Download ppt "VALIDATION AND UPDATING OF MODELS WITH BIOMARKERS"

Similar presentations


Ads by Google